COCHW Company Profile and Key Details

Average 10-day trading volume of 88.08 thousand shares is significantly above the 3-month average of 21.72 thousand, indicating heightened recent market interest.

Envoy Medical, Inc. earnings surprise history is a mixed track record. The quarter that ended August 10, 2026, missed forecasts by -12.5%. The prior quarter beat by -42.86%. Over the last six quarters, Apple has recorded several small beats. These include -4.03% in July 31, 2025.

Envoy Medical, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.04. This means the shares are trading above this model’s fair value.

The stock is currently mid-range between its 52-week high and low $0.04 and $0.05. With a market capitalization of about $904.80 thousand, Envoy Medical, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.72). Key stats such as the average daily volume over the past year has been around 15.12 thousand shares, in line with its 52-week average. Headquartered in White Bear Lake, MN, Envoy Medical, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Brent T. Lucas, the company employs approximately 43 people and listed since March 01, 2021. Specializing in auditory health, Envoy Medical, Inc. crafts medical technologies designed to address the full spectrum of hearing impairment.

Our AI price prediction model suggests that Envoy Medical, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Envoy Medical, Inc. trading at a premium to the broader market with a P/E of -1.1.

Envoy Medical, Inc. trades at a P/E ratio of -1.1, slightly below the S&P 500 average, with a price-to-sales ratio of 74.36 and a price-to-book ratio of 23.31 reflecting a rich premium to book value. The P/FCF stands at -0.71, also above market averages. Compared to sector medians, Envoy Medical, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.